Shed Review: Following the GLP-1 Care Handoffs From Intake to Refills

A home-delivered prescription can look like one service even when several businesses are responsible for getting it to you. That distinction matters with Shed. Its website markets weight-management treatment, coaching and medication delivery under one brand, while its terms identify Shed Holdings, LLC as an administrative and communications platform—not the medical practice providing treatment. This review follows those handoffs: who evaluates you, who prescribes, who dispenses, how support works and what happens when another payment comes due.

The public documentation consulted October 19, 2026 describes branded medicines, compounded injections and sublingual products, along with monthly and longer-duration plans. It also contains conflicting prices and membership fees, plus product descriptions that require clarification. Shed documents a potentially convenient service structure, but not a single, fully resolved pathway for every patient. Before enrolling, the useful task is to identify the exact product, clinical entity, pharmacy, billing schedule and follow-up obligations attached to your particular offer.

At a glance

Clinical responsibility: Shed Holdings, LLC operates the platform; independent professional entities and their licensed providers are responsible for evaluations, prescribing and follow-up.
Sources: [8]
Consultation format: Intake starts with an advertised five-minute health-history form. A live virtual consultation may be required depending on the state and treatment.
Sources: [5]
Compounded injection pricing: Semaglutide lists $199, $179 or $159 per month for one-, six- or twelve-month plans; tirzepatide lists $299, $269 or $239. The tables alone do not establish upfront collection or shipment quantities.
Sources: [9] [6]
Renewal and cancellation: Medication programs automatically renew on either 28-day or monthly billing cycles. Cancellation requires at least 72 hours’ notice before the next charge.
Sources: [8]
Delivery limits: Standard shipping is advertised at no additional cost, but the consulted documentation does not establish a general GLP-1 arrival deadline or identify each patient's dispensing pharmacy.
Sources: [5] [8]

Start by separating the platform from the medical practice

Shed’s homepage describes a telehealth clinic covering weight loss, hair health, sexual wellness and longevity. Its contractual description is narrower: Shed Holdings, LLC owns and operates the website but does not practice medicine or provide diagnosis or treatment. Independent, physician-owned or licensed professional entities, described collectively as the Provider Group, deliver clinical services through affiliated licensed healthcare providers. A provider should not automatically be assumed to be a physician.

Those independent entities control evaluations, prescriptions, treatment plans and follow-up schedules. The distinction is practical, not merely corporate: account support and medical decision-making belong to different responsibilities. Our guide to clinicians and telehealth platforms explains why patients should know which organization holds each role. The consulted documentation does not identify the Provider Group entities by legal name or independently establish individual professional licenses.

Shed says it offers telehealth in all 50 states, but also says treatment availability varies with medical and regulatory requirements. Its terms make the patient’s physical location during the visit relevant to the available clinician, medicine and consultation format. Enrollment requires being at least 18 and located in a U.S. state where services are available. Nationwide platform availability therefore does not establish nationwide access to every advertised product.

Sources: [8] [5]

The intake form is a starting point, not a prescription

The advertised first step is a roughly five-minute form covering health history and preferred administration method. Although some website language suggests no appointment is needed, the homepage FAQ provides the important qualification: some patients meet virtually with a licensed medical provider, while others may have their online assessment reviewed without a live appointment. The applicable state and treatment help determine which route is available.

Shed’s Wegovy catalog describes adults with a BMI of at least 30, or at least 27 with a weight-related condition such as hypertension, diabetes or high cholesterol. That is a product-page description, not automatic approval or a general eligibility rule for every compounded offering. The consulted documentation does not establish comprehensive laboratory requirements, contraindications or product-specific screening criteria across the entire weight-management catalog.

For preparation, assemble questions about the proposed medicine, existing medications, supplements, allergies and pregnancy plans rather than treating a preferred route as the final decision. NIDDK identifies these discussions as part of medication selection. The independent clinician must decide whether treatment is appropriate. Shed does not document a general clinical-review turnaround here, so completing a short form should not be read as promising a prescription—or approval within five minutes.

Sources: [5] [4] [8] [2]

Confirm the product and route before discussing delivery

Shed’s catalog includes compounded semaglutide and tirzepatide injections described as weekly products. Separate pages advertise semaglutide-containing liquid drops and lozenges used under the tongue. The lozenge page’s description of steady absorption through the oral mucosa is a provider claim, not independent evidence establishing performance. These presentations should remain distinct when asking about a prescription; sharing an ingredient name does not make every route the same product.

The branded pages describe access, if approved, to Wegovy as a once-daily pill or weekly pen and Zepbound as tirzepatide in a vial. Shed also markets Foundayo as once-daily oral orforglipron and describes it as FDA-approved for chronic weight management. That regulatory statement is reported as Shed’s claim, not independently verified here. Its comparison language alternates between “same active ingredient” and “same class,” despite identifying different ingredients. Confirm the exact product rather than relying on those comparisons.

The broader catalog also lists a metformin, naltrexone and topiramate capsule and MIC plus B12 injections. For compounded products, Shed acknowledges the absence of FDA review or approval for safety, effectiveness and quality. FDA recommends compounding when an individual’s medical needs cannot be met by an approved drug; nonapproval alone does not prove clinical inequivalence. Our product and formulation checklist helps separate ingredient, route, presentation and dispensing questions.

Sources: [5] [13] [3] [11] [7] [10] [6] [1]

The payment handoff is not uniform across products

The compounded injection tables present different monthly equivalents for one-, six- and twelve-month plans. They do not, by themselves, say whether longer plans are collected upfront, how much medicine each shipment contains or what early cancellation costs. Shed advertises unchanged GLP-1 plan prices when a provider increases the prescribed amount, but that claim does not resolve plan-specific commitments. Drops explicitly include medication and supplies; their inclusion language should not automatically be applied to every other offering.

Branded pages separate pharmacy payment from Shed’s membership and provider fee, but do not reconcile their competing amounts. Wegovy’s clarification gives starting monthly medication prices of $149 for pills and $199 for pens for new cash-pay patients, excluding a $99 Shed fee. Another block lists $349–499 for medication, without specifying that amount’s period, plus $125 monthly membership. An additional $99-per-month card does not clarify whether medication is included.

Zepbound likewise has an opening claim from $149 monthly plus $125 membership, a clarification from $349 monthly for new cash-pay patients plus a $99 Shed fee, and another $349–499 medication block plus $125 monthly membership. These are unresolved differences, not interchangeable quotes. Foundayo starts at $149 monthly for new cash-pay patients, excluding a $125 Shed membership/provider fee, with medication paid separately to the pharmacy; the quoted clarification does not specify the fee’s billing interval.

Documented prices that require product-specific confirmation
Offering	Published price	Important condition
Compounded semaglutide injections	$199/month: one month; $179/month: six months; $159/month: twelve months	Longer-plan tables do not establish upfront payment or shipment quantity.
Compounded tirzepatide injections	$299/month: one month; $269/month: six months; $239/month: twelve months	The lowest monthly equivalent belongs to the twelve-month plan.
Semaglutide-containing sublingual drops	Starting at $229/month	Specific product section includes medication, supplies, member support and free shipping.
Semaglutide sublingual lozenges	Month-to-month, starting at $199/month	Specific section lists member support and free shipping.
Branded medicine programs	Medication payment plus a separate Shed fee	Wegovy and Zepbound pages conflict on prices and membership amounts.

Sources: [9] [6] [5] [13] [3] [10] [11] [7]

A partner list does not identify your dispensing pharmacy

Shed’s terms list Strive Compounding Pharmacy, Promise Pharmacy, DCA Pharmacy, Everwell Pharmacy, Custom Ivy Pharmacy and Boothwyn Pharmacy as partners. That establishes a documented network, not the assignment for a particular prescription. A pharmacy described as dispensing a branded product is not thereby documented as compounding it. Before payment, request the name and contact details of the pharmacy expected to fill your specific order.

The terms also allow transfers among partner pharmacies and make no guarantee about a medication’s place of origin. They contemplate direct shipments from outside the United States, including the United Kingdom, Canada and other locations. This qualifies the impression created by references to U.S. pharmacies elsewhere in the marketing. It does not establish where any individual order will originate, which is precisely why the patient-specific assignment matters.

The practical prescription-to-pharmacy handoff involves more than receiving a tracking number. Ask who will answer formulation, label and storage questions, whether the pharmacy assignment can change and which organization handles an order problem. The consulted documentation does not independently verify pharmacy licenses or provide a complete patient-specific dispensing pathway. Shed’s public partner list is useful orientation, but it is not a substitute for knowing who actually fills the prescription.

Sources: [8] [11] [7]

Separate approval, shipping and safe receipt

Shed advertises standard shipping at no additional cost, and its branded medicine pages describe pharmacy fulfillment and home delivery after approval. Neither statement sets a general GLP-1 arrival deadline. The specific seven-to-ten-business-day estimate found in the consulted documentation concerns women’s hair treatment and runs from provider approval. It should not be repurposed as a GLP-1 delivery promise or measured from initial registration.

For an actual order, ask separately about clinical review, prescription transmission, pharmacy processing, dispatch and expected arrival. Those are different milestones, and a dispatch notice is not proof of receipt. The documentation does not establish a universal support-response deadline or a standard GLP-1 shipping window. Confirm the contact route for a delayed or missing package before the first shipment rather than assuming the account team and pharmacy have identical responsibilities.

Temperature concerns require a clearer boundary than a delivery estimate. FDA explicitly advises not using an injectable GLP-1 medicine that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Our guide to warm injectable deliveries explains that advice. This is general FDA guidance, not evidence of a Shed-specific delivery problem; the consulted material does not establish a provider-specific rate of shipping or refrigeration failures.

Sources: [5] [11] [7] [12] [1]

Ongoing support has several different channels

Shed’s member portal is described as the access point for medical providers, nursing support, health coaching, wellness resources and account or order assistance. The homepage advertises a dedicated coach and dietitian, plus follow-up appointments when needed. The tirzepatide page adds unlimited provider follow-ups, step-by-step health courses and access to Pivot, a tracking app for recording administrations, side effects, habits and progress.

Those offerings should not be collapsed into one promise of unlimited live clinical access. The terms describe certain memberships as including one fifteen-minute virtual coaching appointment each month and emphasize that membership is separate from medication cost. Free text-based coaching may include AI-generated responses; Shed says a licensed coach monitors and reviews those communications. Automated coaching, a scheduled coaching appointment and a medical follow-up are different services with different responsibilities.

The useful question is which channel handles a clinical concern and how quickly it responds, rather than simply whether “support” is included. Shed does not document a general response-time commitment in the consulted material. NIDDK describes follow-up as assessing tolerance and response, not merely continuing payments. Patients should obtain their program’s clinical contact instructions and check-in schedule, while recognizing that app tracking and coaching do not themselves establish access to a prescriber.

Sources: [5] [6] [8] [2]

Refill duties continue even when a subscription renews

Shed’s medication programs renew automatically, with billing either every 28 days or monthly depending on the program. Those intervals are not equivalent. The terms require cancellation at least 72 hours before the next billing date; later requests apply to the following month. The stated portal route is “My Treatments,” then “Manage Subscription.” Canceling future charges should not be mistaken for receiving a refund of an existing charge.

Membership fees become nonrefundable after treatment approval, while the terms promise a membership-fee refund if a licensed provider does not approve treatment. If medication is not shipped because a patient fails to submit a refill form or attend a required visit, that month remains ineligible for a refund. Shed may offer a discretionary one-time future shipment credit after requirements are completed, provided the subscription remains active; this is not an automatic remedy.

The refund policy also refers to a two-month minimum commitment, but its applicability across plans is unclear. The consulted terms excerpt has an omitted intermediate section, limiting a complete contract assessment. A marketed guarantee is conditional on eligibility, check-ins and treatment adherence, and the full procedure for the advertised 120-day guarantee is unavailable here. Obtain the applicable commitment, refill requirements and guarantee exclusions in writing before treating renewal or cancellation as straightforward.

Sources: [8] [6]

Questions & answers

Will I have a live appointment before a Shed prescription?

Possibly. Shed says the format depends on your state and treatment: a licensed provider may review the online assessment without a live visit, or a virtual appointment may be required. The independent clinical entity determines the appropriate process. Ask which format applies before assuming that the advertised short intake form completes the evaluation.

Sources: [5] [8]

Does Shed require insurance, and can I use HSA or FSA funds?

Shed says insurance is not required and describes programs designed to operate without going through insurance. It also says eligible HSA or FSA cards can pay for qualifying treatments and services. That is not confirmation that every expense qualifies under your plan. The documentation does not establish specific insurer coverage, prior-authorization services or individual copays.

Sources: [5]

What do Shed’s needle-free GLP-1 products cost?

The dedicated liquid-drops section starts at $229 monthly and includes medication, supplies, member support and free shipping. The lozenge section advertises month-to-month pricing starting at $199 monthly, member support and free shipping. Both pages mix in Wegovy material and other pricing, so their broader $149 headlines should not be treated as clear prices for these sublingual products.

Sources: [13] [3]

Which pharmacy will fill my Shed prescription?

The public terms name several partners but do not establish the pharmacy assigned to you. They also allow partner transfers and do not guarantee U.S. origin. Ask for the dispensing pharmacy’s identity, direct contact information and the expected shipping origin for your actual order. A network listing alone does not answer those patient-specific questions.

Sources: [8]

Does unlimited follow-up mean unlimited coaching appointments?

Not necessarily. The tirzepatide page advertises unlimited provider follow-ups, while the terms describe certain memberships as including one fifteen-minute virtual coaching appointment monthly. Text coaching is another channel and may incorporate AI-generated responses under stated coach oversight. Confirm the benefits attached to your plan rather than treating medical follow-up, coaching and automated messaging as interchangeable.

Sources: [6] [8] [5]

Can I get a refund if I cancel before medicine ships?

Cancellation alone does not establish refund eligibility. Membership becomes nonrefundable after treatment approval, and a missed refill requirement can leave a month nonrefundable even without shipment. The terms promise a membership refund if treatment is not approved. Ask which charge is refundable and under which provision; do not assume that an unshipped order or canceled subscription reverses all payments.

Sources: [8]

Our assessment

Shed documents a broad care pathway: online intake, independent clinical evaluation, pharmacy fulfillment, home shipping and several ongoing support channels. Its portal and explicit refill responsibilities provide useful operational detail. The main weakness is that the public material does not consistently connect those pieces to one clear product-specific offer. Conflicting branded prices, uncertain pharmacy assignment, unspecified GLP-1 delivery timing and incomplete commitment details make confirmation essential. Before enrolling, request a written summary naming the clinical entity, exact medicine and presentation, dispensing pharmacy, first and recurring charges, billing interval, required check-ins and cancellation terms. Shed offers a documented service structure, but its marketing should not substitute for those individualized operational answers.

Visit Shed’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Shed Review: Following the GLP-1 Care Handoffs From Intake to Refills

At a glance

01Start by separating the platform from the medical practice

02The intake form is a starting point, not a prescription

03Confirm the product and route before discussing delivery

04The payment handoff is not uniform across products

05A partner list does not identify your dispensing pharmacy

06Separate approval, shipping and safe receipt

07Ongoing support has several different channels

08Refill duties continue even when a subscription renews